These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32297247)

  • 1. Gene-to-gene interactions and the association of TP53, XRCC1, TNFα, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females.
    Isakova JT; Vinnikov D; Kipen VN; Talaibekova ET; Aldashev AA; Aldasheva NM; Makieva KB; Semetei Kyzy A; Bukuev NM; Tilekov EA; Shaimbetov BO; Kudaibergenova IO
    Breast Cancer; 2020 Sep; 27(5):938-946. PubMed ID: 32297247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
    Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
    BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study.
    Datkhile KD; Gudur RA; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3065-3075. PubMed ID: 37774058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between polymorphisms of X-ray repair cross-complementing group 1 gene Arg194Trp, Arg399Gln and susceptibility of breast cancer].
    Qian Y; Zhang JP; Dong J; Wang FR; Lin YD; Xu M; Wu LL; Shi P; Shen HB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):242-6. PubMed ID: 20450747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of XRCC1 genetic variants on its tissue expression and breast cancer risk: A case-control study.
    Abdel Ghafar MT; El-Rashidy MA; Gharib F; Al-Ashmawy GM
    Environ Mol Mutagen; 2021 Aug; 62(7):399-408. PubMed ID: 34331480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in DNA repair genes XRCC1 and 3 are associated with increased risk of breast cancer in Bangladeshi population.
    Howlader NR; Rahman MM; Hossain MA; Sultana R; Hossain SM; Mazid MA; Rahman MM
    Breast Cancer Res Treat; 2020 Aug; 182(3):739-750. PubMed ID: 32562117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphism of DNA repair gene X-ray repair cross complementing group 1 and xeroderma pigmentosum group D and environment interaction in non-small-cell lung cancer for Chinese nonsmoking female patients.
    Wang L; Wang LL; Shang D; Yin SJ; Sun LL; Wang XY; Ji HB
    Kaohsiung J Med Sci; 2019 Jan; 35(1):39-48. PubMed ID: 30844146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study.
    Saadat M; Kohan L; Omidvari S
    Breast Cancer Res Treat; 2008 Oct; 111(3):549-53. PubMed ID: 17987379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
    Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
    Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients.
    Zavarikina TM; Khokhlova SV; Tyulyandina AS; Khabas GN; Asaturova AV; Nosova YV; Brenner PK; Kapralova MA; Khodirev DS; Stenina MB
    Bull Exp Biol Med; 2021 Oct; 171(6):755-759. PubMed ID: 34709513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population.
    Macías-Gómez NM; Peralta-Leal V; Meza-Espinoza JP; Gutiérrez-Angulo M; Durán-González J; Ramírez-González JM; Gaspar-Del Toro A; Norberto-Rodríguez A; Leal-Ugarte E
    Fam Cancer; 2015 Sep; 14(3):349-54. PubMed ID: 25690738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the DNA repair gene XRCC1 and breast cancer.
    Duell EJ; Millikan RC; Pittman GS; Winkel S; Lunn RM; Tse CK; Eaton A; Mohrenweiser HW; Newman B; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):217-22. PubMed ID: 11303590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship between Gene Polymorphisms od the XRCC1 and TP53 with the Gender of Children with Acute Leukemia.
    Usenova A; Akhunbaev S; Tumanbaev A; Lim E
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):613-621. PubMed ID: 36853312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
    Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
    Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
    Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
    Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
    Nairuz T; Rahman M; Bushra MU; Kabir Y
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.